CRISPR-Cas-Based Genome Editing for Treating Human Diseases – Part B (Volume 210) (Progress in Molecular Biology and Translational Science, Volume 210)

Author: Singh Ph.D., Vijai

Edition: 1

ISBN: 9780443224201

Release Date: 01-01-2025

Package Dimensions: 9.0 x 6.0 x 0.9 inches

Languages: English

Binding: hardcover

Number Of Pages: 308

Details: CRISPR-Cas-Based Genome Editing for Treating Human Diseases, Part B represents CRISPR-Cas systems for genome editing. Currently, CRISPR-Cas systems have been proven to be a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution. Chapters in this release include Current approaches in CRISPR –Cas systems for metabolic disorders, Recent progress in CRISPR –Cas systems for CRISPR for retinal diseases, Recent progress in CRISPR –Cas systems for cataract and blindness, Advances in CRISPR –Cas systems for muscular dystrophy, Recent development in CRISPR –Cas systems for cardiac disease, Current approaches in CRISPR –Cas systems for diabetes, and much more.

Additional sections cover Advances in CRISPR –Cas systems for liver disease, Advances in CRISPR –Cas systems for lung disease, Advances in CRISPR –Cas systems for kidney diseases, Current progress in CRISPR –Cas systems for rare disease, Advances in CRISPR –Cas systems for heredity disease, Recent progress in CRISPR –Cas systems for neurological disorders, and CRISPR challenges in clinical developments. Provides CRISPR-Cas systems for metabolic disorders, retinal disease cataracts, and blindness Offer updates on muscular dystrophy, cardiac disease, diabetes, and liver disease Includes content on lung disease, kidney diseases, rare diseases, heredity diseases, neurological disorders, and CRISPR challenges in clinical developments